Status:
COMPLETED
Probing Homeostatic Plasticity With Priming Theta-burst Stimulation of the Dorsolateral Prefrontal Cortex
Lead Sponsor:
Dr Georg Kranz
Conditions:
Depression Minor
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Priming stimulation is a highly promising tool to boost the beneficial effects of therapeutic repetitive transcranial magnetic stimulation (rTMS) in psychiatry. The potentiating effects of priming sti...
Detailed Description
No detailed description
Eligibility Criteria
Inclusion
- age 18-35
- education level of primary six or above
- right-handedness
- normal or corrected-to-normal vision
- being able to understand the verbal instructions
- willingness to sign the informed consent form
Exclusion
- a history of seizures
- current or past psychiatric disorders
- current or past severe internal or neurological illness
- ferromagnetic implants \<20cm from the head, cardiac pacemaker, deep brain stimulation and other common TMS exclusion criteria
- history of substance dependence or abuse within the last 3 months
- intake of any medication known to affect the excitation threshold (i.e., benzodiazepines, anticonvulsants).
Key Trial Info
Start Date :
May 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 16 2024
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04031105
Start Date
May 23 2021
End Date
January 16 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hong Kong Polytechnic University
Hong Kong, Hong Kong